Friedli Corporate Finance GmbH is a venture capital firm that invests in early stage companies. The firm focuses on biotechnology and technology sectors. It prefers to invest in companies predominately located in the U.S. The firm prefers to exit its investments within a period of three to five years.

It provides financing through private placements, equity or equity linked securities, valuation, and opinions. The firm seeks to take a board seat at its portfolio companies. It also provides advice on corporate issues such as structuring, management recruiting, strategic issues, and compensation plans. Friedli Corporate Finance GmbH was founded in 1986 and is based in Steinhausen, Switzerland.